CLICHY, France--(BUSINESS WIRE)--CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French ...

First-of-its-kind heart pump implanted in Australia, based on a breakthrough wave membrane technology. Unlike existing devices, CorWave’s technology does not eliminate the effects of the native ...

CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production CorWave, a French company developing and manufacturing innovative ...

- Existing syndicate joined by the EIC Fund, a multi-billion-euro venture capital fund set up by the European Commission that becomes shareholder of a private company for the first time - Funding will ...

Corwave SA raised €26 million (US$28 million) in the second close of its series C funding round taking the total amount to €61 million. The funds will go toward the industrial development of the ...

Primary endpoint successfully met, no device-related serious adverse events at 30 days Pulsatility preserved throughout the study with beat-to-beat valve opening Successful transplantation after 84 ...

CLICHY, France--(BUSINESS WIRE)--CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular ...

Blood pump maker CorWave reeled in a €15.5 million ($17.1 million) Series B, which the French company will put toward a first-in-man study of its novel left ventricular assist device technology, which ...

CorWave, a French company developing and manufacturing innovative cardiac assist devices, announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations. Dawn ...